Detai Bioscience, Inc. (“DetaiBio”), is a CRO vendor focusing on antibody discovery and functional protein research field. DetaiBio is aiming to provide high quality and economic offer service to speed up life science for our client in different fields, such as antibody drug discovery, in-vitro diagnosis and academic research.
Currently, DetaiBio has established different platforms including FACS sorting, plasma cell sorting, hybridoma sequencing, single cell sequencing, structure analysis, High-throughput recombinant protein/recombinant antibody, stable cell line development etc, to support service upgrading, internal R&D and high QC standard.
The main services offer by DetaiBio:
----SingleB® for antibody/VHH discovery service
----High-throughput recombinant antibody expression service (2 week delivery),
----Hybridoma sequencing service
----Customize protein expression service ( E. coli, Mammalian)
Detaibio will continue more efforts to accelerate the research in life science (biotech and biopharma industry, IVD and academic field), to achieve the win-win for both DetaiBio and our partners.
Company Details
- Founded
- 2013
- Address
- Spokane, Wa 99201-0508, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.detaibio.us/
- HQ
- Spokane, WA
Detai Bioscience, Inc. Questions
Detai Bioscience, Inc.'s website is http://www.detaibio.us/
Detai Bioscience, Inc.'s LinkedIn profile is https://www.linkedin.com/company/detaibio
Detai Bioscience, Inc.'s industry is
Biotechnology Research
Detai Bioscience, Inc.'s top competitors are
Okay Biotechnology Co., Ltd,
Thermo Fisher Scientific,
Isogenica,
Thrive Biosafety,
Appiture Biotechnologies, Inc.,
Getein Biotech, Inc.,
Biocytogen,
Nanomath Llc,
Vazyme,
Biointron.
Detai Bioscience, Inc.'s categories are Biotechnology Research
Detai Bioscience, Inc.'s founding year is 2013
